1. P1‐033: A candidate reference method for analysis of amyloid beta 1‐42 (Aß1‐42) peptide in human CSF using 2D‐HPLC with a xevo t q‐s mass spectrometer. (1st July 2015) Authors: Korecka, Magdalena; Waligórska, Teresa; Figurski, Michal; Pannee, Josef; Portelius, Erik; Zetterberg, Henrik; Blennow, Kaj; Trojanowski, John Q.; Shaw, Leslie M. Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7S:Part 7 Page Start: P349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1‐119: Prospective quality‐control monitoring in the context of a clinical trial. (1st July 2015) Authors: Figurski, Michal J.; Waligórska, Teresa; Brylska, Magdalena; Korecka, Magdalena; Fields, Leona; Shah, Nirali; Pan, Sarah; Siemers, Eric R.; Lachno, David R.; Deckard, Deanilee; Dean, Robert A.; Trojanowski, John Q.; Shaw, Leslie M. Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7S:Part 8 Page Start: P386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P2‐143: Method Comparison of AB(1‐42) Measured in Human Cerebrospinal Fluid Samples by Liquid Chromatography‐Tandem Mass Spectrometry, the Inno‐Bia ALZBIO3 Assay, and the Elecsys® B‐Amyloid(1‐42) Assay. (1st July 2016) Authors: Shaw, Leslie M.; Fields, Leona; Korecka, Magdalena; Waligórska, Teresa; Trojanowski, John Q.; Allegranza, Deirdre; Bittner, Tobias; He, Ying; Morgan, Kelly; Rabe, Christina Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 13 Page Start: P668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗